Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma.

Mouhammed Amir HabraBettzy StephenMatthew CampbellKenneth HessCoya TapiaMingxuan XuJordi Rodon AhnertCamilo JimenezJeffrey E LeeNancy D PerrierRussell R BoraddusShubham PantVivek SubbiahDavid S HongAbdulrazzak ZarifaSiqing FuDaniel D KarpFunda Meric-BernstamAung Naing

Published in: Journal for immunotherapy of cancer (2019)

ClinicalTrials.gov identifier: NCT02721732 , Registered March 29, 2016.

Keyphrases

phase ii
clinical trial
open label
advanced non small cell lung cancer
double blind
phase iii
placebo controlled
study protocol